A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study

[1]  Kath Wright,et al.  PTSD in prison settings: A systematic review and meta-analysis of comorbid mental disorders and problematic behaviours , 2019, PloS one.

[2]  S. Kaasa,et al.  Renal function and symptoms/adverse effects in opioid‐treated patients with cancer , 2015, Acta anaesthesiologica Scandinavica.

[3]  P. Lawlor,et al.  Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic , 2015, Pain research & management.

[4]  D. Anghelescu,et al.  Patient‐controlled analgesia at the end of life at a pediatric oncology institution , 2015, Pediatric blood & cancer.

[5]  D. Pei,et al.  The Safety and Effectiveness of Patient-controlled Analgesia in Outpatient Children and Young Adults With Cancer: A Retrospective Study , 2015, Journal of pediatric hematology/oncology.

[6]  M. Montanari,et al.  Assessing the response to opioids in cancer patients: a methodological proposal and the results , 2015, Supportive Care in Cancer.

[7]  J. Höijer,et al.  Low Vitamin D Levels Are Associated with Higher Opioid Dose in Palliative Cancer Patients – Results from an Observational Study in Sweden , 2015, PloS one.

[8]  S. Periasamy,et al.  Influences of gender on postoperative morphine consumption. , 2014, Journal of clinical and diagnostic research : JCDR.

[9]  H. Bozcuk,et al.  Determinants of opioid efficiency in cancer pain: a comprehensive multivariate analysis from a tertiary cancer centre. , 2014, Asian Pacific journal of cancer prevention : APJCP.

[10]  E. Bruera,et al.  The routine use of the Edmonton classification system for cancer pain in an outpatient supportive care center. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  T. Hechler,et al.  Chronic pain treatment in children and adolescents: less is good, more is sometimes better , 2014, BMC Pediatrics.

[12]  Ji-Young Park,et al.  OPRM1 A118G Gene Variant and Postoperative Opioid Requirement: A Systematic Review and Meta-analysis , 2014, Anesthesiology.

[13]  Kristi Muldoon-Jacobs,et al.  Infant toxicology: state of the science and considerations in evaluation of safety. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[14]  S. Mercadante,et al.  Pharmacological management of cancer pain in children. , 2014, Critical reviews in oncology/hematology.

[15]  Laura A. Cariola,et al.  PROSPERO International prospective register of systematic reviews , 2017 .

[16]  P. Niravath.  Aromatase inhibitor-induced arthralgia: a review. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[17]  S. Kaasa,et al.  Variability in UDP-glucuronosyltransferase genes and morphine metabolism: observations from a cross-sectional multicenter study in advanced cancer patients with pain , 2013, Pharmacogenetics and genomics.

[18]  A. Dahan,et al.  Pharmacovigilance: a review of opioid-induced respiratory depression in chronic pain patients. , 2013, Pain physician.

[19]  S. Kaasa,et al.  Opioids in pain management of mesothelioma and lung cancer patients , 2013, Acta oncologica.

[20]  F. Fulfaro,et al.  Meaningful cut-off pain intensity for breakthrough pain changes in advanced cancer patients , 2013, Current medical research and opinion.

[21]  S. Mercadante.  Pharmacotherapy for Breakthrough Cancer Pain , 2012, Drugs.

[22]  Cho Y. Lam,et al.  Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse. , 2012, The journal of pain : official journal of the American Pain Society.

[23]  Y. Kagawa,et al.  Impact of cachexia on pharmacokinetic disposition of and clinical responses to oxycodone in cancer patients , 2012, European Journal of Clinical Pharmacology.

[24]  S. Kaasa,et al.  Which domains should be included in a cancer pain classification system? Analyses of longitudinal data , 2012, PAIN.

[25]  S. Mercadante.  Switching methadone: a 10-year experience of 345 patients in an acute palliative care unit. , 2012, Pain medicine.

[26]  T. Yamanaka,et al.  Prospective study evaluating the plasma concentrations of twenty-six cytokines and response to morphine treatment in cancer patients. , 2011, Anticancer research.

[27]  M. Taniwaki,et al.  Factors Predicting Requirement of High-dose Transdermal Fentanyl in Opioid Switching From Oral Morphine or Oxycodone in Patients With Cancer Pain , 2011, The Clinical journal of pain.

[28]  T. Nakagawa,et al.  Advantage of early induction of opioid to control pain induced by irradiation in head and neck cancer patients. , 2011, Auris, nasus, larynx.

[29]  S. Mercadante,et al.  The Use of High Doses of Oxycodone in an Acute Palliative Care Unit , 2011, The American journal of hospice & palliative care.

[30]  I. Lin,et al.  Symptom patterns of patients with head and neck cancer in a palliative care unit. , 2011, Journal of palliative medicine.

[31]  S. Kaasa,et al.  Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  P. Fayers,et al.  Which variables are associated with pain intensity and treatment response in advanced cancer patients?— Implications for a future classification system for cancer pain , 2011, European journal of pain.

[33]  S. Mercadante,et al.  Prevalence of Opioid-Related Dysuria in Patients With Advanced Cancer Having Pain , 2011, The American journal of hospice & palliative care.

[34]  S. Deandrea,et al.  Epidemiology and Pattern of Care of Breakthrough Cancer Pain in a Longitudinal Sample of Cancer Patients: Results From the Cancer Pain Outcome Research Study Group , 2011, The Clinical journal of pain.

[35]  J. Oh,et al.  Psychological Distress as a Negative Survival Factor for Patients with Hematologic Malignancies Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation , 2010, Pharmacotherapy.

[36]  Y. Lai,et al.  Clinical Experience With Strong Opioids in Pain Control of Terminally ill Cancer Patients in Palliative Care Settings in Taiwan , 2010 .

[37]  E. Bruera,et al.  An international multicentre validation study of a pain classification system for cancer patients. , 2010, European journal of cancer.

[38]  C. Goh,et al.  Opioid use amongst cancer patients at the end of life. , 2010, Annals of the Academy of Medicine, Singapore.

[39]  V. Guastella,et al.  [Neuropathic pain in cancer.]. , 2009, Bulletin du cancer.

[40]  M. Maltoni,et al.  Normal-release Oral Morphine Starting Dose in Cancer Patients With Pain , 2009, The Clinical journal of pain.

[41]  S. Mercadante,et al.  Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. , 2009, Journal of pain and symptom management.

[42]  S. Mackey,et al.  Pain outcomes: A brief review of instruments and techniques , 2009, Current pain and headache reports.

[43]  S. Candrilli,et al.  Impact of Constipation on Opioid Use Patterns, Health Care Resource Utilization, and Costs in Cancer Patients on Opioid Therapy , 2009, Journal of pain & palliative care pharmacotherapy.

[44]  S. Liang,et al.  Factors influencing opioid‐taking self‐efficacy and analgesic adherence in Taiwanese outpatients with cancer , 2008, Psycho-oncology.

[45]  Erik Michel,et al.  Stop the pain! A nation‐wide quality improvement programme in paediatric oncology pain control , 2008, European journal of pain.

[46]  E. Bruera,et al.  Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use. , 2008, Journal of palliative medicine.

[47]  E. Bruera,et al.  Alcoholism screening in advanced cancer patients: Impact on symptom burden and opioid use , 2008 .

[48]  J. Droney,et al.  Constipation in cancer patients on morphine , 2008, Supportive Care in Cancer.

[49]  G. Kurita,et al.  Cognitive Impairment in Cancer Pain Patients Receiving Opioids: A Pilot Study , 2008, Cancer nursing.

[50]  J. Farrar,et al.  A titration strategy is needed to manage breakthrough cancer pain effectively: observations from data pooled from three clinical trials. , 2007, Journal of palliative medicine.

[51]  S. Mercadante,et al.  Opioid escalation in patients with cancer pain: the effect of age. , 2006, Journal of pain and symptom management.

[52]  L. Mayes,et al.  Preoperative Anxiety, Postoperative Pain, and Behavioral Recovery in Young Children Undergoing Surgery , 2006, Pediatrics.

[53]  E. Nemergut,et al.  Postoperative Nausea and Vomiting and Pain After Transsphenoidal Surgery: A Review of 877 Patients , 2006, Anesthesia and analgesia.

[54]  D. Walsh,et al.  The Adverse Effects of Morphine: A Prospective Survey of Common Symptoms During Repeated Dosing for Chronic Cancer Pain , 2006, The American journal of hospice & palliative care.

[55]  A. Adunsky,et al.  High Dose Controlled-Release Oxycodone in Hospice Care , 2006, Journal of pain & palliative care pharmacotherapy.

[56]  A. Vigano,et al.  A multicenter study of the revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. , 2005, Journal of pain and symptom management.

[57]  A. Adunsky,et al.  Patterns of high‐dose morphine use in a home‐care hospice service , 2004, Cancer.

[58]  D. Tripathy,et al.  No evidence for sex differences in the severity and treatment of cancer pain. , 2004, Journal of pain and symptom management.

[59]  M. Groenvold,et al.  Pain characteristics and treatment outcome for advanced cancer patients during the first week of specialized palliative care. , 2004, Journal of pain and symptom management.

[60]  E. Gracely,et al.  The terminal cancer patient: effects of age, gender, and primary tumor site on opioid dose. , 2003, Pain medicine.

[61]  G. Ljungman,et al.  Characteristics and adequacy of intravenous morphine infusions in children in a paediatric oncology setting. , 2003, Medical and pediatric oncology.

[62]  M. DeBaun,et al.  Rapid increase of morphine and benzodiazepine usage in the last three days of life in children with cancer is related to neuropathic pain. , 2003, The Journal of pediatrics.

[63]  E. Kharasch,et al.  Gender differences in drug effects: implications for anesthesiologists , 2003, Acta anaesthesiologica Scandinavica.

[64]  G. Tuncel,et al.  Preoperative emotional states in patients with breast cancer and postoperative pain , 2003, Acta anaesthesiologica Scandinavica.

[65]  D. Fairclough,et al.  Development of a cancer pain prognostic scale. , 2002, Journal of pain and symptom management.

[66]  A. Patenaude,et al.  Cancer and children: where are we coming from? Where are we going? , 2001, Psycho-oncology.

[67]  J. Finkelstein,et al.  Use of the CAGE questionnaire for screening problem drinking in an out-patient palliative radiotherapy clinic. , 2001, Journal of pain and symptom management.

[68]  W. Clark,et al.  Preoperative Multidimensional Affect and Pain Survey (MAPS) scores predict postcolectomy analgesia requirement. , 2000, The Clinical journal of pain.

[69]  F. Fulfaro,et al.  Opioid responsiveness-primary diagnosis relationship in advanced cancer patients followed at home. , 2000, Journal of pain and symptom management.

[70]  P. Gagnon,et al.  Delirium in terminal cancer: a prospective study using daily screening, early diagnosis, and continuous monitoring. , 2000, Journal of pain and symptom management.

[71]  F. Fulfaro,et al.  Factors influencing the opioid response in advanced cancer patients with pain followed at home: the effects of age and gender , 2000, Supportive Care in Cancer.

[72]  T. Morita,et al.  Contributing factors to physical symptoms in terminally-ill cancer patients. , 1999, Journal of pain and symptom management.

[73]  S. Mercadante,et al.  Methadone response in advanced cancer patients with pain followed at home. , 1999, Journal of pain and symptom management.

[74]  A. Adunsky,et al.  High dose morphine use in the hospice setting , 1999, Cancer.

[75]  G. Hanks,et al.  Morphine, constipation and performance status in advanced cancer patients , 1999, Palliative medicine.

[76]  A. Vigano,et al.  Age, pain intensity, and opioid dose in patients with advanced cancer , 1998, Cancer.

[77]  S. Mercadante.  Opioid responsiveness in patients with advanced head and neck cancer , 1998, Supportive Care in Cancer.

[78]  G. Dardanoni,et al.  Monitoring of opioid therapy in advanced cancer pain patients. , 1997, Journal of pain and symptom management.

[79]  E. Zecca,et al.  Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients. , 1996, Journal of Clinical Oncology.

[80]  G. Fountzilas,et al.  Intraventricular administration of morphine for control of intractable cancer pain in 90 patients. , 1996, Neurosurgery.

[81]  E. Bruera,et al.  A prospective multicenter assessment of the Edmonton staging system for cancer pain. , 1995, Journal of pain and symptom management.

[82]  K. Syrjala,et al.  Evidence for a biopsychosocial model of cancer treatment-related pain , 1995, Pain.

[83]  H. Thaler,et al.  Opioid responsiveness of cancer pain syndromes caused by neuropathic or nociceptive mechanisms , 1994, Neurology.

[84]  P. Poulain,et al.  Is disease progression the major factor in morphine ‘tolerance’ in cancer pain treatment? , 1993, Pain.

[85]  P. Glare,et al.  Dose-ranging study of oxycodone for chronic pain in advanced cancer. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[86]  S. Mercadante,et al.  Predictive factors in advanced cancer pain treated only by analgesics , 1992, Pain.

[87]  W. Rees.  Opioid needs of terminal care patients: variations with age and primary site. , 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

[88]  Robert F. Kaiko,et al.  Sources of variation in analgesic responses in cancer patients with chronic pain receiving morphine , 1983, Pain.

[89]  W. Bunney,et al.  Stress-induced plasma beta-endorphin immunoreactivity may predict postoperative morphine usage , 1982, Psychiatry Research.

[90]  R. Kaiko.  Age and morphine analgesia in cancer patients with postoperative pain. , 1981, Clinical pharmacology and therapeutics.

[91]  J. Wordliczek,et al.  Age influence on opioid consumption in terminally ill digestive cancer patients , 2013 .

[92]  N. Magrini,et al.  WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses , 2012 .

[93]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[94]  K. Clément,et al.  Pharmacology of Morphine in Obese Patients , 2009, Clinical pharmacokinetics.

[95]  R. D. du Bois,et al.  No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. , 2006, Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

[96]  J. Ferlay,et al.  Globocan 2000 : cancer incidence, mortality and prevalence worldwide , 2001 .

[97]  C. Nordborg,et al.  Spinal epidural metastasis: implications for spinal analgesia to treat "refractory" cancer pain. , 1997, Journal of pain and symptom management.

[98]  D. Pickar,et al.  The relationship of plasma cortisol and beta-endorphin immunoreactivity to surgical stress and postoperative analgesic requirement. , 1983, General hospital psychiatry.